489
Views
2
CrossRef citations to date
0
Altmetric
Research Article

Design, synthesis, characterization and in vitro antimicrobial evaluation of 4,6-diaryl-4,5-dihydro-2-phenyl-2H-indazol-3-ols

, &
Pages 480-486 | Received 14 Feb 2008, Accepted 15 May 2008, Published online: 01 Apr 2009

References

  • M Balasubramanian, and A D'Souza. (1968). Studies on the reduction of some substituted cyclohexanones. Tetrahedron 24:5399–5408.
  • Cecchi L, Melani F, Filacchioni G, Tredici M. Synthesis and biological activity of some 3-(pyrazol-1′-yl)indazole derivatives Farmaco, 1984;39:945–952.
  • JH Ko, SW Yeon, JS Ryu, KT Yong, SE Ha, YH Jung, PR Eun, and RC Kyu. (2006). Synthesis and biological evaluation of 5-arylamino-6-chloro-1H-indazole-4,7-diones as inhibitors of protein kinase B/Akt. Bioorg Med Chem Lett 16:6001–6005.
  • A Gerpe, G Aguirre, L Boiani, H Cerecetto, M Gonzalez, C Olea-Azar, C Rigol, JD Maya, A Morello, OE Piro, VJ Aran, A Azqueta, AL de Cerain, A Monge, MA Rojas, and G Yaluff. (2006). Indazole N-oxide derivatives as antiprotozoal agents: Synthesis, biological evaluation and mechanism of action studies. Bioorg Med Chem 14:3467–3480.
  • X Li, S Chu, VA Feher, M Khalili, Z Nie, S Margosiak, V Nikulin, J Levin, KG Sprankle, ME Tedder, R Almassy, K Appelt, and KM Yager. (2003). Structure-Based design, synthesis, and antimicrobial activity of indazole-derived SAH/MTA nucleosidase inhibitors. J Med Chem 46:5663–5673.
  • DL Selwood, DG Brummell, J Budworth, GE Burtin, RO Campbell, S Chana, IG Charles, PA Fernandez, RC Glen, MC Goggin, AJ Hobbs, MR Kling, Q Liu, DJ Madge, S Meillerais, KL Powell, K Reynolds, GD Spacey, JN Stables, MA Tatlock, KA Wheelers, G Wishart, and C Woo. (2001). Synthesis and biological evaluation of novel pyrazoles and indazoles as activators of the nitric oxide receptor, soluble guanylate cyclase. J Med Chem 44:78–93.
  • M Gopalakrishnan, P Sureshkumar, J Thanusu, V Kanagarajan, R Govindaraju, and GA Jayasri. (2007). A convenient ‘one-pot’ synthesis and in vitro microbiological evaluation of novel 2,7-diaryl-[1,4]-diazepan-5-ones. J Enz Inhib Med Chem 22:709–715.
  • M Gopalakrishnan, P Sureshkumar, J Thanusu, C Prabhu, and V Kanagarajan. (2007). One-pot conversion of piperidine-4-ones to [1,4]-diazepan-5-ones under microwave irradiation using silica gel supported NaHSO4 catalyst. J Chem Res 2:80–81.
  • M Gopalakrishnan, P Sureshkumar, V Kanagarajan, and J Thanusu. (2007). Design, ‘one-pot’ synthesis, characterization, antibacterial and antifungal activities of novel 6-aryl-1,2,4,5-tetrazinan-3-thiones in dry media. J Sulf Chem 28:383–392.
  • T Balasankar, M Gopalakrishnan, and S Nagarajan. (2007). Synthesis and anti-bacterial activity of some 5-(4-biphenyl)-7-aryl[3,4-d]-1,2,3-benzoselenadiazoles. J Enz Inhib Med Chem 22:171–175.
  • T Balasankar, M Gopalakrishnan, and S Nagarajan. (2005). Synthesis and antibacterial activity of some 5-(4-biphenylyl)-7-aryl[3,4-d][1,2,3]-benzothiadiazoles. Eur J Med Chem 40:728–731.
  • MH Dhar, MM Dhar, BN Dhawan, BN Mehrotra, and C Ray. (1968). Screening of Indian plants biological activity. Part I. Indian J Exp Biol 6:232–247.
  • W Guthrie, and XP Wang. (1991). The aldol condensation of acetophenone with acetone. Can J Chem 69:339.
  • W Guthrie. (1991). Rate-equilibrium correlations for the aldol condensation: an analysis in terms of Marcus theory. J Am Chem Soc 113:7249.
  • AT Nielson, and WJ Houlihan. (1968). The aldol condensation. Org React 16:1–438.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.